In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
23hon MSN
Safety net provider alleged pharmacy benefit manager collaborated with a rival to set low payment rates to pharmacies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback